Form 4: Eastman Chemical SVP Granted Stock Options, RSUs
Executive Compensation Grant
Julie A. McAlindon, SVP at Eastman Chemical Co., received grants of 24,364 stock options and 3,352 restricted stock units.
Summary
- Julie A. McAlindon, SVP, Regions & Chief Supply Chain Officer for Eastman Chemical Co. (EMN), was granted 24,364 employee stock options and 3,352 restricted stock units (RSUs) on February 24, 2026.
- The employee stock options have an exercise price of $77.12 and will vest in three equal annual installments, becoming exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively, with an expiration date of February 23, 2036.
- Each restricted stock unit represents a contingent right to receive one share of Eastman Chemical common stock.
- The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices aimed at retaining key talent and aligning management incentives with long-term company performance.
Positives
- The grant of stock options and restricted stock units aligns executive compensation with shareholder interests.
- The multi-year vesting schedules for both the options and RSUs incentivize long-term retention and performance of a key executive.
Negatives
- Potential for future minor dilution of existing shares upon the exercise of options and vesting of RSUs.
Future Outlook
The grants include multi-year vesting schedules, indicating a forward-looking compensation structure designed to retain and incentivize the executive through February 2029 for RSUs and full option vesting, with options expiring in February 2036.
Industry Context
StockSavvy.ai notes that executive compensation packages, particularly those involving equity grants like stock options and restricted stock units, are standard practice across the chemicals industry and broader corporate landscape. These grants are designed to align executive incentives with long-term shareholder value creation and are a common tool for executive retention.
Comparison to Industry Standards
- StockSavvy.ai observes that the use of performance-based equity compensation, such as stock options and restricted stock units with multi-year vesting, is a common practice among peer companies in the specialty chemicals sector, including firms like Dow Inc., LyondellBasell Industries, and PPG Industries. These structures are generally considered best practice for executive retention and aligning management interests with long-term shareholder value, similar to how executives at these comparable companies are compensated.
Stakeholder Impact
- Shareholders: Potential for minor future dilution upon exercise/vesting, but also benefits from incentivized executive performance.
- Employees: Reflects standard executive compensation practices, potentially signaling stability in leadership.
Next Steps
- One-third of the granted stock options will become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively.
- The restricted stock units will vest and payout in unrestricted shares of Company common stock on February 24, 2029, subject to continued employment.
Key Dates
| Date | Description |
|---|---|
| 02/24/2026 | Date of grant for employee stock options and restricted stock units. |
| 02/26/2026 | Date the Form 4 was signed by Power of Attorney. |
| 02/24/2027 | First vesting date for one-third of the employee stock options. |
| 02/24/2028 | Second vesting date for one-third of the employee stock options. |
| 02/24/2029 | Third and final vesting date for one-third of the employee stock options, and vesting/payout date for restricted stock units. |
| 02/23/2036 | Expiration date for the employee stock options. |
Recommendation
holdThis filing details a routine executive compensation grant and does not contain information that would typically warrant a change in investment recommendation. It reflects standard corporate governance and compensation practices.
Keywords
Eastman Chemical Co., EMN, Stock Options, Restricted Stock Units, RSUs, Executive Compensation, Insider Transaction, Form 4, Julie A. McAlindon, SVP, Supply Chain Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.